Danny Eckert, PhD: Pharmacotherapies Reducing OSA Severity
Proof-of-concept studies using a targeted phenotypic approach to reduce obstructive sleep apnea severity are showing exciting results.
Danny Eckert, PhD: Unlocking New Targets For Pharmacological Therapy In OSA
The identification of 3 key non-anatomical contributors to OSA has unlocked new potential pharmacotherapies, a major advance for the field.
2 Clarke Drive Cranbury, NJ 08512